News

SterileCare Inc. Reaches Key Enrollment Milestone in Innovative Catheter Lock Solution Trial

dicentra congratulates SterileCare on achieving a significant milestone in their innovative catheter lock solution clinical trial, with 20 patients enrolled…

12 months ago

Penn Medicine Becker ENT & Allergy Features Castle Connolly Awarded Doctors in 2024

Celebrating excellence in ENT care with recognized physicians in New Jersey and Philadelphia. PRINCETON, NEW JERSEY / ACCESSWIRE / January…

12 months ago

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia

BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development…

12 months ago

AI/ML Innovations Inc. Announces Appointment of Peter Kendall as President and Chief Commercialization Officer

Accomplished Commercialization Leader to Drive Global Growth.Proven Expertise in Scaling Health Tech Businesses - Mr. Kendall Brings a Track Record…

12 months ago

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

CARMEL, Ind., Jan. 06, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology…

12 months ago

Editas Medicine to Present at the 43rd Annual J.P. Morgan Healthcare Conference

CAMBRIDGE, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced…

12 months ago

Rendever Launches Alcove Sanctuary: A New VR Application Featuring an AI Family Companion

VR app features Nova, the new embodied AI companion that sparks conversation and adventure from the comfort of the homeBOSTON,…

12 months ago

Senti Bio Announces Additional $11.5 Million of Financing

– Approximately $10 million additional investment in private placement equity financing – – $1.5 million from CIRM grant first announced…

12 months ago

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

IRVINE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused…

12 months ago

AAMI Updates Materials Compatibility Guidance for EO, Other Modalities

Document Updated for the First Time Since 2017Arlington, Virginia, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Whether a material is compatible…

12 months ago